Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ependymoma × ibrutinib × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 42 Lymphoma, Mantle-Cell 17 Lymphoma, Follicular 12 Waldenstrom Macroglobulinemia 11 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, B-Cell 9 Lymphoma 9 Lymphoma, Non-Hodgkin 8 Leukemia 8 Recurrence 7 Multiple Myeloma 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphoid 4 Leukemia, B-Cell 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms, Plasma Cell 2 Lung Neoplasms 2 Leukemia, Prolymphocytic 2 Leukemia, Myeloid, Acute 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Chromosome 17 deletion 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Bronchiolitis Obliterans Syndrome 2 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1

Interventions

Temozolomide 7 Magnetic Resonance Spectroscopy 5 Bevacizumab 5 X-Rays 4 Phantoms, Imaging 4 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Carboplatin 3 Lapatinib 2 Everolimus 2 Etoposide 2 Erlotinib Hydrochloride 2 Biopsy 2 veliparib 1 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 pomalidomide 1 poly ICLC 1 picropodophyllin 1 palbociclib 1 olaparib 1 marizomib 1 larotrectinib 1 imetelstat 1 erdafitinib 1 dinutuximab 1 bempegaldesleukin 1 antineoplaston AS 2-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡